Optic pathway glioma

What it is

An optic pathway glioma is a usually low-grade glioma (often a pilocytic astrocytoma) that arises in the optic pathways — the nerves and structures carrying vision from the eyes to the brain. It is common in children, especially those with neurofibromatosis type 1 (NF1), and can affect vision.

Understanding Optic pathway glioma

Because these tumors involve the visual pathways, complete surgical removal is usually not possible without damaging vision, so management differs from other gliomas. Many optic pathway gliomas, particularly in children with NF1, grow slowly and may not need immediate treatment; they are monitored with imaging and careful vision testing. When treatment is needed — for example, if vision is threatened or the tumor is growing — chemotherapy is typically the first choice (to avoid radiation in young children), and MAPK-targeted therapy (MEK inhibitors) is increasingly used. Surgery is reserved for specific situations. The goal is to preserve vision and function. Children with NF1 are often screened for these tumors with regular eye examinations. Understanding optic pathway glioma clarifies a usually low-grade visual-pathway tumor managed to protect vision.

Why it matters

Understanding optic pathway glioma helps families see a usually low-grade tumor of the visual pathways — common in NF1 — that is often managed with observation or chemotherapy rather than surgery, to protect vision.